699 related articles for article (PubMed ID: 19330170)
1. The value of drug repositioning in the current pharmaceutical market.
Tobinick EL
Drug News Perspect; 2009 Mar; 22(2):119-25. PubMed ID: 19330170
[TBL] [Abstract][Full Text] [Related]
2. Trends in risks associated with new drug development: success rates for investigational drugs.
DiMasi JA; Feldman L; Seckler A; Wilson A
Clin Pharmacol Ther; 2010 Mar; 87(3):272-7. PubMed ID: 20130567
[TBL] [Abstract][Full Text] [Related]
3. [Biomarkers: "Found in translation"].
Lockhart BP; Walther B
Med Sci (Paris); 2009 Apr; 25(4):423-30. PubMed ID: 19409197
[TBL] [Abstract][Full Text] [Related]
4. The year's new drugs and biologics--2007.
Graul AI; Prous JR; Barrionuevo M; Bozzo J; Castaner R; Cruces E; Revel L; Rosa E; Serradell N; Sorbera LA
Drug News Perspect; 2008; 21(1):7-35. PubMed ID: 18301807
[TBL] [Abstract][Full Text] [Related]
5. The year's new drugs & biologics - 2008.
Graul AI; Revel L; Barrionuevo M; Cruces E; Rosa E; Verges C; Lupone B; Diaz N; Castaner R
Drug News Perspect; 2009; 22(1):7-29. PubMed ID: 19209296
[TBL] [Abstract][Full Text] [Related]
6. Brazil: An emerging partner in drug R&D.
Rodrigues DG
IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
[TBL] [Abstract][Full Text] [Related]
7. Keynote review: Is declining innovation in the pharmaceutical industry a myth?
Schmid EF; Smith DA
Drug Discov Today; 2005 Aug; 10(15):1031-9. PubMed ID: 16055019
[TBL] [Abstract][Full Text] [Related]
8. From biomarker strategies to biomarker activities and back.
van Gool AJ; Henry B; Sprengers ED
Drug Discov Today; 2010 Feb; 15(3-4):121-6. PubMed ID: 19931413
[TBL] [Abstract][Full Text] [Related]
9. Drug repurposing and adverse event prediction using high-throughput literature analysis.
Deftereos SN; Andronis C; Friedla EJ; Persidis A; Persidis A
Wiley Interdiscip Rev Syst Biol Med; 2011; 3(3):323-34. PubMed ID: 21416632
[TBL] [Abstract][Full Text] [Related]
10. Drug development: from concept to marketing!
Tamimi NA; Ellis P
Nephron Clin Pract; 2009; 113(3):c125-31. PubMed ID: 19729922
[TBL] [Abstract][Full Text] [Related]
11. Strategies for bringing drug delivery tools into discovery.
Kwong E; Higgins J; Templeton AC
Int J Pharm; 2011 Jun; 412(1-2):1-7. PubMed ID: 21421040
[TBL] [Abstract][Full Text] [Related]
12. Synthetic therapeutic peptides: science and market.
Vlieghe P; Lisowski V; Martinez J; Khrestchatisky M
Drug Discov Today; 2010 Jan; 15(1-2):40-56. PubMed ID: 19879957
[TBL] [Abstract][Full Text] [Related]
13. Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines.
Correia ML; Haynes WG
Expert Opin Emerg Drugs; 2005 Aug; 10(3):643-60. PubMed ID: 16083333
[TBL] [Abstract][Full Text] [Related]
14. Portfolio management in early stage drug discovery - a traveler's guide through uncharted territory.
Betz UA
Drug Discov Today; 2011 Jul; 16(13-14):609-18. PubMed ID: 21600301
[TBL] [Abstract][Full Text] [Related]
15. Model-based drug development: a rational approach to efficiently accelerate drug development.
Milligan PA; Brown MJ; Marchant B; Martin SW; van der Graaf PH; Benson N; Nucci G; Nichols DJ; Boyd RA; Mandema JW; Krishnaswami S; Zwillich S; Gruben D; Anziano RJ; Stock TC; Lalonde RL
Clin Pharmacol Ther; 2013 Jun; 93(6):502-14. PubMed ID: 23588322
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial drug discovery: is it all downhill from here?
Projan SJ; Shlaes DM
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():18-22. PubMed ID: 15522036
[TBL] [Abstract][Full Text] [Related]
17. The year's new drugs and biologics--2006.
Graul AI; Sorbera LA; Bozzo J; Serradell N; Revel L; Prous JR
Drug News Perspect; 2007; 20(1):17-44. PubMed ID: 17332898
[TBL] [Abstract][Full Text] [Related]
18. Mining small-molecule screens to repurpose drugs.
Swamidass SJ
Brief Bioinform; 2011 Jul; 12(4):327-35. PubMed ID: 21715466
[TBL] [Abstract][Full Text] [Related]
19. [The discovery process in the pharmaceutical industry].
Scatton B
J Soc Biol; 2009; 203(3):249-69. PubMed ID: 19833071
[TBL] [Abstract][Full Text] [Related]
20. The cost of developing imaging agents for routine clinical use.
Nunn AD
Invest Radiol; 2006 Mar; 41(3):206-12. PubMed ID: 16481902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]